688189 南新制药
已收盘 07-30 15:00:00
资讯
新帖
简况
股价“20cm”涨停!南新制药称正在筹划购买某一国内药品技术等资产组事项
北京商报官方账号 · 11:30
股价“20cm”涨停!南新制药称正在筹划购买某一国内药品技术等资产组事项
公司有什么产品可以用于治疗基孔肯雅热病症吗?南新制药:公司暂未生产和销售治疗该病症的药品
每日经济新闻 · 10:46
公司有什么产品可以用于治疗基孔肯雅热病症吗?南新制药:公司暂未生产和销售治疗该病症的药品
南新制药:股票交易异常波动 筹划购买药品技术资产组事项
格隆汇 · 10:23
南新制药:股票交易异常波动 筹划购买药品技术资产组事项
7月30日南新制药(688189)龙虎榜数据:机构净卖出1096.71万元
证券之星 · 09:15
7月30日南新制药(688189)龙虎榜数据:机构净卖出1096.71万元
科创板收盘播报:科创50指数跌1.11% 部分生物制药股活跃
新华财经 · 07:37
科创板收盘播报:科创50指数跌1.11% 部分生物制药股活跃
异动快报:南新制药(688189)7月30日10点7分触及涨停板
证券之星 · 02:10
异动快报:南新制药(688189)7月30日10点7分触及涨停板
禽流感概念盘中拉升,南新制药涨15.80%
市场透视 · 01:40
禽流感概念盘中拉升,南新制药涨15.80%
龙头上调业绩指引 CXO板块上演“王者归来”
创业板观察 · 07-29 13:08
龙头上调业绩指引 CXO板块上演“王者归来”
7月29日南新制药(688189)龙虎榜数据:机构净买入8896.37万元
证券之星 · 07-29 09:15
7月29日南新制药(688189)龙虎榜数据:机构净买入8896.37万元
南新制药涨5.01% 资金博弈与政策扰动催生股价波动
智选洞察 · 07-29 05:31
南新制药涨5.01% 资金博弈与政策扰动催生股价波动
每周股票复盘:南新制药(688189)因收盘价格涨幅达15%首登龙虎榜
证券之星 · 07-19
每周股票复盘:南新制药(688189)因收盘价格涨幅达15%首登龙虎榜
禽流感概念盘中拉升,生物股份等2只股票涨停
市场透视 · 07-17
禽流感概念盘中拉升,生物股份等2只股票涨停
肿瘤治疗概念盘中拉升,南新制药涨9.42%
市场透视 · 07-17
肿瘤治疗概念盘中拉升,南新制药涨9.42%
南新制药股价下跌5.05% 抗流感业务承压与资金博弈共振
智选洞察 · 07-16
南新制药股价下跌5.05% 抗流感业务承压与资金博弈共振
7月14日南新制药(688189)龙虎榜数据:机构净买入1007.35万元
证券之星 · 07-14
7月14日南新制药(688189)龙虎榜数据:机构净买入1007.35万元
仿制药一致性评价概念盘中拉升,南新制药涨7.09%
市场透视 · 07-14
仿制药一致性评价概念盘中拉升,南新制药涨7.09%
南新制药上涨6.34%,报8.55元/股
金融界 · 07-14
南新制药上涨6.34%,报8.55元/股
南新制药涨5.10% 政策预期与资金博弈扰动股价
智选洞察 · 07-14
南新制药涨5.10% 政策预期与资金博弈扰动股价
南新制药股价小幅回落 公司专注抗流感药物研发
金融界 · 07-11
南新制药股价小幅回落 公司专注抗流感药物研发
仿制药一致性评价概念盘中拉升,海王生物涨8.50%
市场透视 · 07-02
仿制药一致性评价概念盘中拉升,海王生物涨8.50%
加载更多
公司概况
公司名称:
湖南南新制药股份有限公司
所属行业:
医药制造业
上市日期:
2020-03-26
主营业务:
湖南南新制药股份有限公司的主营业务是专注于流行性感冒等抗病毒、传染病防治药品,以及恶性肿瘤、心脑血管疾病、糖尿病等其他重大疾病治疗药品研发、生产与销售。公司的主要产品是帕拉米韦氯化钠注射液、磷酸奥司他韦干混悬剂、辛伐他汀分散片、阿托伐他汀钙片、贝那普利氢氯噻嗪片、头孢呋辛酯分散片、头孢克洛胶囊、头孢克洛干混悬剂、乳酸环丙沙星氯化钠注射液、复方布洛芬片、布洛芬混悬滴剂、布洛芬混悬液、盐酸非索非那定口服混悬液。
发行价格:
34.94
{"stockData":{"symbol":"688189","market":"SH","secType":"STK","nameCN":"南新制药","latestPrice":14.28,"timestamp":1753858800000,"preClose":11.9,"halted":0,"volume":50528578,"delay":0,"changeRate":0.2,"floatShares":274000000,"shares":274000000,"eps":-1.397,"marketStatus":"已收盘","change":2.38,"latestTime":"07-30 15:00:00","open":11.9,"high":14.28,"low":11.9,"amount":693000000,"amplitude":0.2,"askPrice":0,"askSize":0,"bidPrice":14.28,"bidSize":5102,"shortable":0,"etf":0,"ttmEps":-1.397,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753925400000},"marketStatusCode":5,"adr":0,"adjPreClose":11.9,"symbolType":"stock_kcb","openAndCloseTimeList":[[1753839000000,1753846200000],[1753851600000,1753858800000]],"highLimit":13.09,"lowLimit":10.71,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":274400000,"isCdr":false,"pbRate":4.22,"roa":"--","roe":"--","epsLYR":-1.3007,"committee":0,"marketValue":3918000000,"turnoverRate":0.1841,"status":0,"afterMarket":{"amount":0,"volume":0,"close":14.28,"buyVolume":4859,"sellVolume":0,"time":1753860838019,"indexStatus":"已收盘 07-30 15:30:00","preClose":11.9},"floatMarketCap":3918000000},"requestUrl":"/m/hq/s/688189","defaultTab":"news","newsList":[{"id":"2555946046","title":"股价“20cm”涨停!南新制药称正在筹划购买某一国内药品技术等资产组事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2555946046","media":"北京商报官方账号","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555946046?lang=zh_cn&edition=full","pubTime":"2025-07-30 19:30","pubTimestamp":1753875009,"startTime":"0","endTime":"0","summary":"北京商报讯(记者 丁宁)7月30日晚间,南新制药(688189)发布公告称,公司近期正在筹划购买某一国内药品技术等资产组事项,尚无法确定是否构成重大资产重组。该事项正处于筹划阶段,尚未签署任何有关收购的意向协议,是否能够顺利实施存在重大不确定性。公司将根据该事项的进展情况及时履行信息披露义务,具体内容以公司后续公告为准。公告显示,南新制药股票交易连续三个交易日内(7月28日—30日)收盘价格涨幅偏离值累计达到30%,根据《上海证券交易所交易规则》《上海证券交易所科创板股票异常交易实时监控细则》的有关规定,属于股票交易异常波动的情形。7月30日,南新制药收涨20%,收盘价为14.28元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730193228a6c9a68e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730193228a6c9a68e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2555043595","title":"公司有什么产品可以用于治疗基孔肯雅热病症吗?南新制药:公司暂未生产和销售治疗该病症的药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2555043595","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555043595?lang=zh_cn&edition=full","pubTime":"2025-07-30 18:46","pubTimestamp":1753872390,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:公司有什么产品可以用于治疗基孔肯雅热病症吗?南新制药(688189.SH)7月30日在投资者互动平台表示,公司暂未生产和销售治疗该病症的药品。(记者 谭玉涵)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073018472994c3af43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073018472994c3af43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2555010532","title":"南新制药:股票交易异常波动 筹划购买药品技术资产组事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2555010532","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555010532?lang=zh_cn&edition=full","pubTime":"2025-07-30 18:23","pubTimestamp":1753871004,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2555011079","title":"7月30日南新制药(688189)龙虎榜数据:机构净卖出1096.71万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555011079","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555011079?lang=zh_cn&edition=full","pubTime":"2025-07-30 17:15","pubTimestamp":1753866924,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年7月30日公布的交易公开信息显示,南新制药因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券,有价格涨跌幅限制的连续3个交易日内收盘价格涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年7月30日收盘,南新制药报收于14.28元,上涨20.0%,涨停,换手率18.41%,成交量50.53万手,成交额6.93亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出1096.71万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073000027790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2555013132","title":"科创板收盘播报:科创50指数跌1.11% 部分生物制药股活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2555013132","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555013132?lang=zh_cn&edition=full","pubTime":"2025-07-30 15:37","pubTimestamp":1753861033,"startTime":"0","endTime":"0","summary":"至收盘时,科创50指数报1058.57点,跌幅1.11%,指数振幅为2.12%,总成交额约353.2亿元。从盘面上看,科创板个股多数下跌,上涨个股132只。细分领域中,少数生物制药、化学制药类个股表现活跃,元器件、半导体、软件服务类个股下跌。经新华财经统计,7月30日,科创板589只个股平均跌幅0.91%,平均换手率3.51%,合计成交额1630亿元,平均振幅为4.40%。成交额方面,寒武纪成交额53亿元,位居首位;ST帕瓦成交额999.6万元,位居末位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073015373494c35ad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073015373494c35ad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159371","688189","000688","688131","159982","BK0242"],"gpt_icon":0},{"id":"2555095648","title":"异动快报:南新制药(688189)7月30日10点7分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2555095648","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555095648?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:10","pubTimestamp":1753841440,"startTime":"0","endTime":"0","summary":"证券之星7月30日盘中消息,10点7分南新制药触及涨停板。目前价格14.28,上涨20.0%。其所属行业化学制药目前上涨。领涨股为上海谊众。该股为流感,医药,创新药概念热股,当日流感概念上涨0.63%,医药概念上涨0.45%,创新药概念上涨0.24%。7月29日的资金流向数据方面,主力资金净流入3990.59万元,占总成交额9.56%,游资资金净流入1704.31万元,占总成交额4.08%,散户资金净流出5694.9万元,占总成交额13.64%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073000010991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2555093388","title":"禽流感概念盘中拉升,南新制药涨15.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555093388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555093388?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:40","pubTimestamp":1753839629,"startTime":"0","endTime":"0","summary":"07月30日,禽流感概念盘中拉升,截至09点40分,禽流感概念整体指数上涨1.00%,报1488.740点。从个股上来看,该概念的成分股中,南新制药涨15.80%,众生药业、佛慈制药、蔚蓝生物涨幅居前。从资金上来看,截止发稿,禽流感概念主力净流入为-1.18亿,其中南新制药受到资金热捧,主力净流入2397.99万;拉长时间线来看,该板块近20日主力资金净流入-19.38亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073009402994c2b9e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073009402994c2b9e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688189","BK0226","603739"],"gpt_icon":0},{"id":"2555052427","title":"龙头上调业绩指引 CXO板块上演“王者归来”","url":"https://stock-news.laohu8.com/highlight/detail?id=2555052427","media":"创业板观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555052427?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:08","pubTimestamp":1753794485,"startTime":"0","endTime":"0","summary":"今日,创新药板块集体发力,CXO方向领涨。消息面上,药明康德昨夜发布半年报并上调全年销售预期。上半年业绩方面,药明康德上半年实现营业收入207.99亿元,同比增长20.64%;归属于上市公司股东的净利润85.61亿元,同比增长101.92%。截至上半年末,药明康德TIDES在手订单同比增长48.8%,服务客户数同比提升12%,服务分子数量同比提升16%。后者则建议关注备全球影响力的CXO龙头企业,以及以国内业务为主的临床CRO龙头。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729221032a6c80240&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729221032a6c80240&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","603456","688189","BK0239","BK0070"],"gpt_icon":0},{"id":"2555039714","title":"7月29日南新制药(688189)龙虎榜数据:机构净买入8896.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555039714","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555039714?lang=zh_cn&edition=full","pubTime":"2025-07-29 17:15","pubTimestamp":1753780504,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年7月29日公布的交易公开信息显示,南新制药因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月29日收盘,南新制药报收于11.9元,上涨17.01%,换手率14.17%,成交量38.87万手,成交额4.17亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入8896.37万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900028605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2555842170","title":"南新制药涨5.01% 资金博弈与政策扰动催生股价波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2555842170","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555842170?lang=zh_cn&edition=full","pubTime":"2025-07-29 13:31","pubTimestamp":1753767094,"startTime":"0","endTime":"0","summary":"南新制药今日盘中表现强势,截至13点30分,股价报10.68元,上涨5.01%。资金博弈与政策扰动催生股价波动南新制药近期股价呈现高频震荡,资金面多空博弈加剧。7月14日龙虎榜显示机构席位单日买入2177.9万元,推动当日股价上涨18%,但政策扰动引发短期避险情绪,如创新药支付端调整导致7月9日主力净流出981.7万元。产品结构与研发进度构筑估值中枢南新制药长期估值受制于产品单一性与研发进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729133141a6c72a64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729133141a6c72a64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2552714412","title":"每周股票复盘:南新制药(688189)因收盘价格涨幅达15%首登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2552714412","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552714412?lang=zh_cn&edition=full","pubTime":"2025-07-20 02:22","pubTimestamp":1752949334,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘,南新制药报收于10.85元,较上周的8.04元上涨34.95%。本周,南新制药7月18日盘中最高价报11.1元,股价触及近一年最高点。南新制药当前最新总市值29.77亿元,在化学制药板块市值排名136/150,在两市A股市值排名4374/5149。本周关注点交易信息汇总:南新制药因收盘价格涨幅达到15%首次登上龙虎榜交易信息汇总沪深交易所2025年7月14日公布的交易公开信息显示,南新制药因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000000545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2552177646","title":"禽流感概念盘中拉升,生物股份等2只股票涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2552177646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552177646?lang=zh_cn&edition=full","pubTime":"2025-07-17 11:12","pubTimestamp":1752721976,"startTime":"0","endTime":"0","summary":"07月17日,禽流感概念盘中拉升,截至11点12分,禽流感概念整体指数上涨1.00%,报1407.080点。从个股上来看,该概念的成分股中,沃华医药涨幅超过10%,生物股份等2只股票涨停,南新制药涨幅超过5%。从资金上来看,截止发稿,禽流感概念主力净流入为7441.16万,其中沃华医药受到资金热捧,主力净流入9646.46万;拉长时间线来看,该板块近20日主力资金净流入-14.94亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071711125695459883&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071711125695459883&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0188","BK0196","600201","BK0012","BK0185","BK0239","BK0077","688189","BK0046"],"gpt_icon":0},{"id":"2552748201","title":"肿瘤治疗概念盘中拉升,南新制药涨9.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552748201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552748201?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:39","pubTimestamp":1752716355,"startTime":"0","endTime":"0","summary":"07月17日,肿瘤治疗概念盘中拉升,截至09点39分,肿瘤治疗概念整体指数上涨0.50%,报1638.360点。从个股上来看,该概念的成分股中,南新制药涨9.42%,复旦张江涨幅超过5%。从资金上来看,截止发稿,肿瘤治疗概念主力净流入为4586.31万,其中信立泰受到资金热捧,主力净流入3350.54万;拉长时间线来看,该板块近20日主力资金净流入-15.93亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071709391597a91b09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071709391597a91b09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2551314116","title":"南新制药股价下跌5.05% 抗流感业务承压与资金博弈共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2551314116","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551314116?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:37","pubTimestamp":1752629879,"startTime":"0","endTime":"0","summary":"南新制药股价大幅下跌,最新价9.58元/股,跌幅达5.05%。资金博弈与政策预期共振南新制药近期股价波动呈现典型资金博弈特征。政策扰动加剧波动,7月9日创新药支付端调整引发资金撤离,次日公司196.7万元回购计划带动部分资金回流。抗流感赛道价值重塑路径作为抗流感药物细分龙头,南新制药该领域营收占比75.08%,但2025年一季度营收同比下滑70.21%,业绩修复仍需观察。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093842a6ac38af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093842a6ac38af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2551901555","title":"7月14日南新制药(688189)龙虎榜数据:机构净买入1007.35万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551901555","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551901555?lang=zh_cn&edition=full","pubTime":"2025-07-14 17:16","pubTimestamp":1752484589,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年7月14日公布的交易公开信息显示,南新制药因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月14日收盘,南新制药报收于9.5元,上涨18.16%,换手率12.53%,成交量34.39万手,成交额3.03亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入1007.35万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400024640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2551920069","title":"仿制药一致性评价概念盘中拉升,南新制药涨7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551920069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551920069?lang=zh_cn&edition=full","pubTime":"2025-07-14 10:30","pubTimestamp":1752460247,"startTime":"0","endTime":"0","summary":"07月14日,仿制药一致性评价概念盘中拉升,截至10点30分,仿制药一致性评价概念整体指数上涨1.05%,报1147.660点。从个股上来看,该概念的成分股中,南新制药涨7.09%,昂利康涨幅超过5%。从资金上来看,截止发稿,仿制药一致性评价概念主力净流入为-3826.55万,其中恒瑞医药受到资金热捧,主力净流入1.18亿;拉长时间线来看,该板块近20日主力资金净流入-73.72亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410304797a51038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410304797a51038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK0188","LU1997244956.HKD","LU1328615791.USD","LU1997245094.SGD","LU2148510915.USD","LU1064130708.USD","LU1997245177.USD","LU1064131003.USD","BK0239","LU1655091616.SGD","LU0405327494.USD","LU0405327148.USD","LU2328871848.SGD","LU2495084118.USD","BK0012","BK0060","BK0196","600276","688189","BK0028","LU1969619763.USD","BK0183"],"gpt_icon":0},{"id":"2551392092","title":"南新制药上涨6.34%,报8.55元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2551392092","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551392092?lang=zh_cn&edition=full","pubTime":"2025-07-14 10:27","pubTimestamp":1752460046,"startTime":"0","endTime":"0","summary":"7月14日,南新制药盘中上涨6.34%,截至10:27,报8.55元/股,成交5627.85万元,换手率2.5%,总市值23.46亿元。资料显示,湖南南新制药股份有限公司位于湖南省长沙市浏阳市经济技术开发区康里路1号,公司主要从事化学药物的研发、生产与营销,专注于重大疾病和突发性疾病的新药和特效药的研发及产业化。截至9月30日,南新制药股东户数9069,人均流通股3.03万股。2024年1月-9月,南新制药实现营业收入2.27亿元,同比减少59.69%;归属净利润-7183.61万元,同比减少11142.92%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/14102751668528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2551827979","title":"南新制药涨5.10% 政策预期与资金博弈扰动股价","url":"https://stock-news.laohu8.com/highlight/detail?id=2551827979","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551827979?lang=zh_cn&edition=full","pubTime":"2025-07-14 10:26","pubTimestamp":1752460013,"startTime":"0","endTime":"0","summary":"南新制药今日股价明显拉升,截至10点26分,最新价为8.45元/股,涨幅达5.10%。资金博弈与政策预期交织扰动股价南新制药近期股价波动显著,截至7月14日10时26分,单日振幅达6.34%,20个交易日累计振幅超18%。当前机构与散户操作持续分化,或反映市场对流感季政策红利的预期分歧。核心赛道价值与估值修复路径作为抗流感药物细分龙头,南新制药该领域营收占比达75.08%,但2025年一季度营收同比下滑70.21%,业绩压力仍存。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714102657a448bd99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714102657a448bd99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2550950174","title":"南新制药股价小幅回落 公司专注抗流感药物研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2550950174","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550950174?lang=zh_cn&edition=full","pubTime":"2025-07-12 00:01","pubTimestamp":1752249703,"startTime":"0","endTime":"0","summary":"南新制药7月11日报收8.04元,较前一交易日下跌0.50%。当日成交量为79797手,成交金额达6400万元。该股开盘报8.12元,盘中最高触及8.20元,最低下探至7.91元,全天振幅3.59%。南新制药是一家专注于抗流感药物研发的医药企业,主要产品包括帕拉米韦氯化钠注射液等抗病毒药物。公司总市值22.06亿元,流通市值与总市值相同。从资金流向来看,7月11日南新制药主力资金净流出267万元,占流通市值的0.12%。近五个交易日累计净流出1640万元。风险提示:股市有风险,投资需谨慎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712001121953efaed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712001121953efaed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2548883221","title":"仿制药一致性评价概念盘中拉升,海王生物涨8.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548883221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548883221?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:35","pubTimestamp":1751420126,"startTime":"0","endTime":"0","summary":"07月02日,仿制药一致性评价概念盘中拉升,截至09点35分,仿制药一致性评价概念整体指数上涨0.65%,报1098.790点。从个股上来看,该概念的成分股中,海王生物涨8.50%,南新制药、乐普医疗等3只股涨幅超过5%。从资金上来看,截止发稿,仿制药一致性评价概念主力净流入为-2038.41万,其中乐普医疗受到资金热捧,主力净流入6250.61万;拉长时间线来看,该板块近20日主力资金净流入-92.24亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093526a72967bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093526a72967bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","BK0168","BK0209","BK0188","BK0239","688189","000078","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753897322312,"stockEarnings":[{"period":"1week","weight":0.4125},{"period":"1month","weight":0.9194},{"period":"3month","weight":1.3182},{"period":"6month","weight":1.3032},{"period":"1year","weight":1.5185},{"period":"ytd","weight":1.1835}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0497},{"period":"3month","weight":0.1027},{"period":"6month","weight":0.1123},{"period":"1year","weight":0.2558},{"period":"ytd","weight":0.0788}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南南新制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8843人(较上一季度减少0.47%)","perCapita":"31030股","listingDate":"2020-03-26","address":"湖南省长沙市浏阳市经济技术开发区康里路1号","registeredCapital":"27440万元","survey":" 湖南南新制药股份有限公司的主营业务是专注于流行性感冒等抗病毒、传染病防治药品,以及恶性肿瘤、心脑血管疾病、糖尿病等其他重大疾病治疗药品研发、生产与销售。公司的主要产品是帕拉米韦氯化钠注射液、磷酸奥司他韦干混悬剂、辛伐他汀分散片、阿托伐他汀钙片、贝那普利氢氯噻嗪片、头孢呋辛酯分散片、头孢克洛胶囊、头孢克洛干混悬剂、乳酸环丙沙星氯化钠注射液、复方布洛芬片、布洛芬混悬滴剂、布洛芬混悬液、盐酸非索非那定口服混悬液。","listedPrice":34.94},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南新制药(688189)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南新制药(688189)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南新制药,688189,南新制药股票,南新制药股票老虎,南新制药股票老虎国际,南新制药行情,南新制药股票行情,南新制药股价,南新制药股市,南新制药股票价格,南新制药股票交易,南新制药股票购买,南新制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南新制药(688189)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南新制药(688189)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}